The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer.
Ugo De Giorgi
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer
Karim Rihawi
No relevant relationships to disclose
Michele Aieta
No relevant relationships to disclose
Giovanni Lo Re
No relevant relationships to disclose
Teodoro Sava
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Sanofi
Cristina Masini
No relevant relationships to disclose
Valentina Baldazzi
No relevant relationships to disclose
Fabio De Vincenzo
No relevant relationships to disclose
Andrea Camerini
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Giuseppe Fornarini
No relevant relationships to disclose
Luciano Burattini
No relevant relationships to disclose
Giovanni Rosti
Honoraria - Amgen; Italfarmaco; Lilly; MSD; Pfizer
Luca I. Moscetti
No relevant relationships to disclose
Vincenzo Emanuele Chiuri
No relevant relationships to disclose
Stefano Luzi Fedeli
No relevant relationships to disclose
Vittorio D. Ferrari
No relevant relationships to disclose
Dino Amadori
No relevant relationships to disclose
Umberto Basso
Honoraria - Bayer; Novartis; Pfizer